Delivery Order SPE2DB22D2206-SPE2DB25FJK77
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 70 mg capsules (90-count units) with a ceiling value of $1,171.95. This is a firm fixed-price delivery order issued under a competitive procurement with no set-aside designation. The contract was awarded on August 22, 2025, with an ultimate completion date of August 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,025.65 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 30 mg capsules (100-count units). The contract was competitively awarded without set-aside provisions and is priced on a firm fixed-price basis, with an ultimate completion date of September 24, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency has awarded a delivery order valued at $1,610.40 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 30 mg capsules (100-count units). This competitively awarded, firm fixed-price contract was executed on August 5, 2025, with an ultimate completion date of August 6, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,977.61 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 30 mg capsules (100 count) on August 22, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order was issued under a child contract arrangement with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 40 mg capsules (100-count) valued at $2,057.66. The contract, which closed on August 28, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be fulfilled from the contractor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate office. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,401.40 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Lisdexamfetamine 30 mg capsules (100 count). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of July 29, 2025. The contract is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 60 mg capsules (90-count) on September 23, 2025, with a ceiling value of $1,073.09 and an ultimate completion date of September 24, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The place of performance is the vendor's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 30 mg capsules (100 count) under a firm fixed-price contract with a ceiling value of $2,136.69. The award, effective September 2, 2025, with an ultimate completion date of September 3, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 50 mg capsules (100 count) with a ceiling value of $6,451.66. The contract was awarded on August 20, 2025, with an ultimate completion date of August 21, 2025, under a firm fixed-price delivery order arrangement. No set-aside designation was utilized in this competitive procurement. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 30 mg capsules (100 count) valued at $8,282.97. The contract, which was competitively awarded with no set-aside designation, was finalized on September 23, 2025, with an ultimate completion date of September 24, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJK77Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,530.00 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 70 mg capsules (90-count packaging) under a firm fixed-price contract type. The award was made on August 14, 2025, with an ultimate completion date of August 15, 2025, and no set-aside designation was utilized in this competitive procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle running through December 2026 that enables comprehensive pharmaceutical and medical supply support to military healthcare programs globally. AmerisourceBergen, a major pharmaceutical distributor and critical federal medical vendor, maintains an extensive portfolio of federal contract awards with the DLA Medical Supply Chain covering diverse therapeutic domains including specialty medications, generics, vaccines, and medical devices. The company demonstrates consistent capability to fulfill federal procurement requirements through competitive awards with flexible delivery order mechanisms supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/14/25 |